Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
149.66
-9.17 (-5.77%)
At close: Aug 26, 2026, 4:00 PM EDT
147.66
-2.00 (-1.34%)
After-hours: Aug 26, 2026, 7:59 PM EDT
Moderna Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2,064 | 1,818 | 3,109 | 6,671 | 18,435 | 17,675 |
Other Revenue | 164 | 126 | 127 | 177 | 828 | 796 |
| 2,228 | 1,944 | 3,236 | 6,848 | 19,263 | 18,471 | |
Revenue Growth | -27.62% | -39.93% | -52.74% | -64.45% | 4.29% | 2200.25% |
Cost of Revenue | 3,699 | 4,000 | 6,007 | 9,538 | 8,711 | 4,608 |
Gross Profit | -1,471 | -2,056 | -2,771 | -2,690 | 10,552 | 13,863 |
Selling, General & Admin | 965 | 1,018 | 1,174 | 1,549 | 1,132 | 567 |
Operating Expenses | 965 | 1,018 | 1,174 | 1,549 | 1,132 | 567 |
Operating Income | -2,436 | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 |
Interest Expense | -42 | -10 | -24 | - | -29 | -17 |
Interest & Investment Income | 282 | 314 | 425 | 421 | 200 | 18 |
Other Non Operating Income (Expenses) | -8 | 7 | -7 | -124 | -16 | -12 |
EBT Excluding Unusual Items | -2,204 | -2,763 | -3,551 | -3,942 | 9,575 | 13,285 |
Gain (Loss) on Sale of Investments | 1 | -5 | -56 | - | - | - |
Pretax Income | -3,087 | -2,768 | -3,607 | -3,942 | 9,575 | 13,285 |
Income Tax Expense | 64 | 54 | -46 | 772 | 1,213 | 1,083 |
Net Income | -3,151 | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 |
Net Income to Common | -3,151 | -2,822 | -3,561 | -4,714 | 8,362 | 12,202 |
Net Income Growth | - | - | - | - | -31.47% | - |
Shares Outstanding (Basic) | 394 | 389 | 384 | 382 | 394 | 403 |
Shares Outstanding (Diluted) | 394 | 389 | 384 | 382 | 416 | 431 |
Shares Change | 1.94% | 1.30% | 0.52% | -8.17% | -3.48% | 13.12% |
EPS (Basic) | -8.01 | -7.25 | -9.27 | -12.34 | 21.22 | 30.28 |
EPS (Diluted) | -8.01 | -7.25 | -9.27 | -12.34 | 20.12 | 28.29 |
EPS Growth | - | - | - | - | -28.88% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1,244 | -2,065 | -4,055 | -3,825 | 4,581 | 13,336 |
Free Cash Flow Per Share | -3.16 | -5.31 | -10.56 | -10.01 | 11.01 | 30.94 |
Gross Margin | -66.02% | -105.76% | -85.63% | -39.28% | 54.78% | 75.05% |
Operating Margin | -109.34% | -158.13% | -121.91% | -61.90% | 48.90% | 71.98% |
Profit Margin | -141.43% | -145.17% | -110.04% | -68.84% | 43.41% | 66.06% |
Free Cash Flow Margin | -55.84% | -106.22% | -125.31% | -55.86% | 23.78% | 72.20% |
EBITDA | -2,195 | -2,859 | -3,756 | -3,618 | 9,768 | 13,528 |
EBITDA Margin | -98.52% | -147.07% | -116.07% | -52.83% | 50.71% | 73.24% |
D&A For EBITDA | 241 | 215 | 189 | 621 | 348 | 232 |
EBIT | -2,436 | -3,074 | -3,945 | -4,239 | 9,420 | 13,296 |
EBIT Margin | -109.34% | -158.13% | -121.91% | -61.90% | 48.90% | 71.98% |
Effective Tax Rate | - | - | - | - | 12.67% | 8.15% |
Revenue as Reported | 2,228 | 1,944 | 3,236 | 6,848 | 19,263 | 18,471 |
Advertising Expenses | - | - | - | - | 121 | - |